Jiunn-Liang Tan1, Zheng-Xin Yong2, Chong-Kin Liam1. 1. Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. 2. Methodist College Kuala Lumpur, Kuala Lumpur, Malaysia.
Abstract
BACKGROUND: Breath alkanes are reported to be able to discriminate lung cancer patients from healthy people. A simple chemiresistor-based sensor was designed to respond to alkanes by a change in resistance measured by a digital multimeter connected to the sensor. In preclinical experiments, the sensor response was found to have a strong positive linear relationship with alkane compounds and not responsive to water. This study aimed to determine the ability of the alkane sensor to distinguish the exhaled breaths of lung cancer patients from that of chronic obstructive pulmonary disease (COPD) patients and control subjects without lung cancer. METHODS: In this cross-sectional study, 12 treatment-naive patients with lung cancer, 12 ex- or current smokers with COPD and 13 never-smokers without lung disease were asked to exhale through a drinking straw into a prototype breath-in apparatus made from an empty 125 mL Vitagen® bottle with the chemiresistor sensor attached at its inside bottom to measure the sensor peak output (percentage change of baseline resistance measured before exhalation to peak resistance) and the time taken for the baseline resistance to reach peak resistance. RESULTS: Analysis of multivariate variance and post-hoc Tukey test revealed that the peak output and the time to peak values for the lung cancer patients were statistically different from that for both the COPD patients and the controls without lung disease, Pillai's Trace =0.393, F=3.909, df = (4, 64), P=0.007. A 2.20% sensor peak output and a 90-s time to peak gave 83.3% sensitivity and 88% specificity in diagnosing lung cancer. Tobacco smoking did not affect the diagnostic accuracy of the sensor. CONCLUSIONS: The alkane sensor could discriminate patients with lung cancer from COPD patients and people without lung disease. Its potential utility as a simple, cheap and non-invasive test for early lung cancer detection needs further studies.
BACKGROUND: Breath alkanes are reported to be able to discriminate lung cancerpatients from healthy people. A simple chemiresistor-based sensor was designed to respond to alkanes by a change in resistance measured by a digital multimeter connected to the sensor. In preclinical experiments, the sensor response was found to have a strong positive linear relationship with alkane compounds and not responsive to water. This study aimed to determine the ability of the alkane sensor to distinguish the exhaled breaths of lung cancerpatients from that of chronic obstructive pulmonary disease (COPD) patients and control subjects without lung cancer. METHODS: In this cross-sectional study, 12 treatment-naive patients with lung cancer, 12 ex- or current smokers with COPD and 13 never-smokers without lung disease were asked to exhale through a drinking straw into a prototype breath-in apparatus made from an empty 125 mL Vitagen® bottle with the chemiresistor sensor attached at its inside bottom to measure the sensor peak output (percentage change of baseline resistance measured before exhalation to peak resistance) and the time taken for the baseline resistance to reach peak resistance. RESULTS: Analysis of multivariate variance and post-hoc Tukey test revealed that the peak output and the time to peak values for the lung cancerpatients were statistically different from that for both the COPDpatients and the controls without lung disease, Pillai's Trace =0.393, F=3.909, df = (4, 64), P=0.007. A 2.20% sensor peak output and a 90-s time to peak gave 83.3% sensitivity and 88% specificity in diagnosing lung cancer. Tobacco smoking did not affect the diagnostic accuracy of the sensor. CONCLUSIONS: The alkane sensor could discriminate patients with lung cancer from COPDpatients and people without lung disease. Its potential utility as a simple, cheap and non-invasive test for early lung cancer detection needs further studies.
Entities:
Keywords:
Alkane sensor; electronic nose; lung cancer
Authors: Wojciech Filipiak; Andreas Sponring; Anna Filipiak; Clemens Ager; Jochen Schubert; Wolfram Miekisch; Anton Amann; Jakob Troppmair Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-01 Impact factor: 4.254
Authors: Wojciech Filipiak; Andreas Sponring; Maria M Baur; Clemens Ager; Anna Filipiak; Helmut Wiesenhofer; Markus Nagl; Jakob Troppmair; Anton Amann Journal: Microbiology Date: 2012-10-11 Impact factor: 2.777
Authors: George Preti; Erica Thaler; C William Hanson; Michelle Troy; Jason Eades; Alan Gelperin Journal: J Chromatogr B Analyt Technol Biomed Life Sci Date: 2009-05-21 Impact factor: 3.205
Authors: Max H M C Scheepers; Zaid Al-Difaie; Lloyd Brandts; Andrea Peeters; Bart van Grinsven; Nicole D Bouvy Journal: JAMA Netw Open Date: 2022-06-01